U.S. News adds patient reviews on doctor profile pages

U.S. News & World Report and Binary Fountain have announced a collaboration that will allow U.S. News to publish patient experience ratings on its doctor profile pages.

Through the data collected from Binary Fountain, U.S. News has now published patient ratings on doctor profile pages to give consumers the ability to compare physicians in as many as 10 different patient metrics. According to a recent survey, 75 percent of Americans reported online ratings have influenced their decisions when choosing a physician. With the newly added reviews, U.S. News aims to assist consumers in making more informed healthcare decisions.

"In the age of healthcare consumerism, patient experience information has become a crucial piece of information for patients and families when choosing a physician," said Chad Smolinski, chief product officer of U.S. News. "Our collaboration with Binary Fountain allows U.S. News to expand the breadth and depth of relevant, trusted data we can provide to patients while searching for a new doctor."

Utilizing Binary Fountains’ Provider Social Index (PSI) technology, which collected patient feedback from over 100 online sources and uses natural language processing to extract insights to create a rating in 10 patient metrics, patient experience data are added to U.S. News doctor profiles. Currently, the reviews on published on family medicine physicians’ pages with more specialties being added in the coming months.

"We are excited to partner with U.S. News to further enhance their doctor profile pages with patient experience ratings, delivering industry-leading insights, data and analytics on thousands of doctors across the country," said Ramu Potarazu, president and CEO of Binary Fountain. "We are confident that our patient experience ratings will further strengthen the patient voice and empower consumers to make better informed decisions, based on doctors' previous track records."

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.